Accreditations


National Association of Boards of Pharmacy (NABP) – Verified-Accredited Wholesale Distributors (VAWD)

The Verified-Accredited Wholesale Distributors(VAWD) program was established in 2004 to help protect the public from the threat of counterfeit drugs. The VAWD program was developed and is administered by the National Association of Boards of Pharmacy (NABP). The program offers an accreditation to wholesale distribution facilities by offering an objective, third-party audit system.

The criteria to earn VAWD accreditation program includes a compliance review, criteria including: licensure verification, on-site survey and examination, screening through NABP’s Clearinghouse, Criminal background checks for responsible persons. The facility must employ security and best practices for safe distribution. Resurveys of accredited sites will be performed by trained NABP surveyors before accreditation may be renewed.


HDA Member – Since November 2012

By definition, primary healthcare distributors purchase medicines and healthcare products directly from manufacturers, and store inventory in their networks of warehouses and distribution centers. Distributors then take orders from healthcare providers, including pharmacies and deliver to them, so products can be dispensed to patients and consumers.

Demand for prescription drugs is driven by increasingly complex interactions between patients, doctors, pharmacy benefit managers, insurers, retailers, government and hospitals. Prescription drug delivery now takes place in a variety of settings, including acute care environments (such as hospitals, urgent care centers and clinics); retail stores; and, mail-order pharmacies. With operations running 24 hours a day, distributors are able to take orders made by 8:00 p.m. in the evening and make them available to healthcare providers and their patients the next morning.

A top priority for HDA and its members is to prevent the misuse and diversion of legitimate products in the nation’s healthcare supply chain.

HDA Member AttainMed


HDA Distributor Members – (as of 9/25/2018)

  • AmerisourceBergen Corporation
  • Anda, Inc.
  • Attain Med, Inc.
  • Auburn Pharmaceutical Company
  • Bloodworth Wholesale Drugs
  • BluPax Pharmaceuticals LLC
  • Capital Wholesale Drug Co.
  • Cardinal Health, Inc.
  • Clint Pharmaceuticals, Inc.
  • CuraScript Specialty Distribution
  • Dakota Drug, Inc.
  • DMS Pharmaceutical Group, Inc.
  • Drogueria Betances, Inc.
  • Health Coalition, Inc.
  • Henry Schein, Inc.
  • HyGen Pharmaceuticals Inc
  • KeySource
  • McKesson Corporation
  • Medisol Pharmaceuticals LLC
  • Miami-Luken, Inc.
  • Morris and Dickson Co., L.L.C.
  • Mutual Wholesale Drug Company
  • PBA Health
  • Prescription Supply, Inc.
  • Prodigy Health Supplier Corporation
  • R&S Northeast LLC
  • RDC
  • Real Value Rx dba Hospital Pharmaceutical Consulting
  • Richie Pharmacal Co., LLC
  • Seacoast Medical LLC
  • Smith Drug Company, Div. J M Smith Corporation
  • Top Rx
  • Value Drug Company
  • VaxServe, a sanofi pasteur company

HDA strongly supports tough, rigorous and consistent standards for state licensing of healthcare distributors as required under federal law. Having strong, consistent distributor licensing is a critical component in ensuring that criminals do not infiltrate the supply chain and gain access to prescription medicines. HDA continues to work with supply chain partners and state and federal officials to develop uniform legislation and regulations pertaining to licensure. Attain Med is proud to have earned full HDA Membership, so you can always buy from us with confidence.


Prescription Drug Abuse

Prescription drug abuse is a serious problem in the U. S.; the Centers for Disease Control and Prevention (CDC) has stated that it has reached epidemic proportions, and the Drug Enforcement Administration has referred to it as the agency’s top priority.

Fundamentally, the solution to this issue must strike a careful balance, to ensure critical medicines are available to legitimate patients with real medical needs, while developing safeguards to prevent abuse. To that end, HDA members have invested heavily in technologies, such as suspicious order monitoring systems and other measures, to further enhance the safety and security of the healthcare supply chain. In March 2012, HDA President and CEO John M. Gray testified on the issue of prescription drug abuse before the House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade, where he indicated that a collaborative approach between industry stakeholders, including state and national legislative/regulatory authorities, will yield more effective results. HDA has partnered with national organizations, such as the National Governors’ Association and The Partnership at Drugfree.org, to educate and raise awareness of this public health challenge.

For more than 140 years, HDA members have been committed to delivering lifesaving healthcare products quickly and safely to providers and patients. Founded in 1876, the organization was originally known as the Western Wholesale Druggists’ Association, which later became the National Wholesale Druggists’ Association, and in 2000 was renamed the Healthcare Distribution Management Association, and again in 2016 it was renamed the Healthcare Distribution Alliance.

In addition to the Association’s 34 primary healthcare distributor members, membership also includes 145 manufacturer and 48 service provider members, respectively. HDA’s mission is:

  • To protect patient safety and access to medicines through the safe efficient distribution of healthcare products and services.
  • To create and exchange industry knowledge and best practices to enhance the value of the healthcare supply chain.
  • To advocate for standards, public policies and business processes that produce safe, innovative and cost-effective healthcare solutions.

Suspicious Order Management

Localized Compliance for Controlled Substance Registrants & Distributors

Federal DEA 21CFR 1301.74b
Suspicious Order Monitoring:
Automatically intercept Orders having significant deviation in:

• Order Size
• Order Frequency
• Order Pattern

Avoid Fines, Cancelled Orders, & Rating Downgrades

Click here to learn more!



D&B BBB HDA SBA NCPA Premier NACDS NMSDC FDA ECRM

Newsletter Sign Up.

Get in touch with us.

Attain Med, Inc.
5825 Glenridge Dr. NE, Bldg. 4, Suite 106
Atlanta, GA 30328

E-mail: information@attainmed.com

Phone: 770-288-2466 | 1 (888) 288-2180
Fax: 1 (888) 288-2181